| Lizenz: Creative Commons Namensnennung 4.0 International (985kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-355421
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.35542
Zusammenfassung
Background: Estrogen receptor beta (ER beta) is expressed in the majority of invasive breast cancer cases, irrespective of their subtype, including triple-negative breast cancer (TNBC). Thus, ER beta might be a potential target for therapy of this challenging cancer type. In this in vitro study, we examined the role of ER beta in invasion of two triple-negative breast cancer cell lines. Methods: ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik